BioDelivery Sciences International (NSDQ:BDSI) said today that it named Peter Ginsberg as its VP of business development.

Prior to joining the Raleigh, N.C.-based company, Ginsberg led business development at United Therapeutics and directed the $350 million sale of the company’s priority review voucher. He has also served as VP of business & technology development for the North Carolina Biotechnology Center, advising and financing emerging biotech companies. Ginsberg also lead acquisitions and licensing transactions for SurModics as the VP of business development & strategic planning.

Get the full story at our sister site, Drug Delivery Business News.